Cargando…

Current status and advances of immunotherapy in nasopharyngeal carcinoma

The general immune landscape of nasopharyngeal carcinoma (NPC) renders immunotherapy suitable for patients with NPC. Immune checkpoint inhibitors (ICIs) based on programmed death-1/programmed death ligand-1 (PD-1/PD-L1) blockade have made a breakthrough with the approval of PD-1 inhibitor for refrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jian-Ying, Wei, Xiao-Li, Wang, Yi-Qin, Wang, Feng-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083041/
https://www.ncbi.nlm.nih.gov/pubmed/35547095
http://dx.doi.org/10.1177/17588359221096214